Prevalence of Metabolic Syndrome in Patients with Psoriasis
Background. Psoriasis is a chronic inflammatory skin disorder in which proinflammatory cytokines including IL-6 and TNF-α increase both locally and systematically. It is thought that chronic inflammation results in metabolic diseases and proinflammatory cytokines give rise to the development of athe...
Saved in:
Main Authors: | Ilkin Zindancı, Ozlem Albayrak, Mukaddes Kavala, Emek Kocaturk, Burce Can, Sibel Sudogan, Melek Koç |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1100/2012/312463 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Evaluation of Thyroid Diseases in Patients with Pemphigus
Vulgaris
by: Mukaddes Kavala, et al.
Published: (2012-01-01) -
Acute Generalized Exanthematous Pustulosis Induced by Etanercept: Another Dermatologic Adverse Effect
by: Mukaddes Kavala, et al.
Published: (2013-01-01) -
The Combined Use of Metformin and Methotrexate in Psoriasis Patients with Metabolic Syndrome
by: Huynh Thi Xuan Tam, et al.
Published: (2022-01-01) -
Systemic Role for Vitamin D in the Treatment of Psoriasis and Metabolic Syndrome
by: Lisa Wenyang Fu, et al.
Published: (2011-01-01) -
The Impact of Psoriasis and Metabolic Syndrome on the Systemic Inflammation and Oxidative Damage to Nucleic Acids
by: Drahomira Holmannova, et al.
Published: (2020-01-01)